healthcare

June 19, 2019

Integrated healthcare platform cure.fit launched its new fitness revolution centre, cult.fit in Dubai at Palm Strip Mall. Headquartered in Bengaluru India, the holistic healthcare company was founded in 2016 by Mukesh Bansal and Ankit Nagori with the aim to address preventive healthcare.

Funded by top investors like Accel Partners, Kalaari Capital, Chiratae Ventures, Ratan Tata, IDG Ventures, Pratithi Investment Trust among others, cure.fit has raised over $ 200 million in funding.

cult.fit has 160 centres spread across six cities"...

Continue Reading >

June 19, 2019

Ferring Pharmaceuticals and WOOM today announced a collaboration, which aims to improve and shorten the fertility journeys of the one in six couples who have difficulty conceiving.1

The WOOM ovulation and fertility app, currently available in Spanish - with registered users across Spain, Mexico, Colombia, Chile, Argentina and Peru - is able to analyse a woman’s menstrual cycle, lifestyle factors and biometrics to help couples better understand their bodies to either help conceive naturally or go and see a specialist as soon as possible. The app was developed in partnership with medical professionals.

As"...

Continue Reading >

June 18, 2019

International Day of Yoga was declared an official global day by the UN General Assembly in 2015, and it takes place annually on June 21, the longest day of the year in the northern hemisphere. Here are some ways to take part in the activities that are being held in Abu Dhabi and Dubai.

Covering Concepts

Thursday, June 20

Covering Concepts hosts a half-day yoga and well-being retreat to promote happiness, physical and mental health and productivity. Take part in five sessions that feature"...

Continue Reading >

June 18, 2019

Aligning with the principles set forth for the “Year of Tolerance,” Fakih IVF Fertility Center is reaching out to individuals in an effort to promote the values of tolerance.

The campaign titled “Positive Mind. Positive Vibes. Positive Results,” stems out from the center’s support of our ruler’s vision of creating a more tolerant nation. As part of the initiative patients will be offered a generous discount on all IVF-ICSI packages along with an additional 10 percent discount on all other packages. This offer can be availed until the end of the month at the center’s branches located in Abu Dhabi, Dubai"...

Continue Reading >

June 18, 2019

Boehringer Ingelheim and OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) today announce that the first patient has been dosed in the first-in-human Phase 1 clinical trial evaluating BI 765063, formerly OSE-172, a first-in-class monoclonal antibody antagonist of SIRPα, being studied in patients with advanced solid tumors. The Phase 1 study is a dose finding study of BI 765063, a myeloid checkpoint inhibitor, administered as a single agent and in combination with Boehringer Ingelheim’s monoclonal antibody PD-1 antagonist BI 754091, a T-lymphocyte checkpoint inhibitor.

“We are very pleased with the progress achieved"...

Continue Reading >

June 12, 2019

Don't panic if you fall sick during the Haj pilgrimage. Pilgrims travelling to Saudi Arabia for Haj this year will be able to connect with their doctor in Dubai via a 24/7 hotline in case a personal health advice is needed.

The Ministry of Health and Prevention (Mohap) and the Dubai Health Authority (DHA) on Tuesday announced the launch of a campaign to ensure the health and safety of Haj pilgrims.

'The international hotline 800-DHA (800342) will connect a pilgrim with their family doctor if they need a personal health consultation,' said Dr Badriya Al Haremi, director"...

Continue Reading >

June 11, 2019

DUBAI, 10th June, 2019 (WAM) -- The UAE Cabinet's approval for the executive regulations of the Federal Law on Medical Liability reinforces the country’s health system and efficiency of medical services, to be at par with the international standards, said the Ministry of Health and Prevention (MoHAP).

In a statement released today, the Ministry underlined that the Cabinet’s approval for the Executive Regulation of the Federal Law No. 4 of 2016 on medical liability comes as part of the country’s strategic drive to develop health legislation as per the highest international standards and in line with the UAE Vision 2021 to"...

Continue Reading >

June 11, 2019

ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South America have sleep apnea, according to a study it presented at the annual SLEEP meeting hosted by the American Academy of Sleep Medicine (AASM) and the Sleep Research Society.

The study, a deeper analysis of ResMed’s 2018 finding that 936 million people worldwide have sleep apnea, concludes that:

  • 170 million people in North and South America (37 percent of adults) have sleep apnea, based on the AASM 2012 criteria – a “conservative” estimate.
  • 3 countries with the highest number of cases are the United States"...

    Continue Reading >

June 11, 2019

  • Boehringer Ingelheim and University of Dundee achieve milestone in collaboration aimed at developing novel protein degradation medicines
  • Results published in Nature Chemical Biology showcase the use of the broadly applicable structure-based PROTAC design approach to discover highly potent and selective drug candidates
  • The first PROTAC is made freely available via Boehringer Ingelheim’s open innovation portal, opnMe
  • Structure-based PROTAC design promises to accelerate the development of therapies against currently intractable cancer drivers

Following the success of their ongoing alliance, Boehringer Ingelheim and the University of Dundee extend their collaboration"...

Continue Reading >

June 11, 2019

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced results of a new post-hoc analysis of data from the EMPA-REG OUTCOME® trial. These results indicated that the effect of empagliflozin on reducing cardiovascular and renal risk was consistent between a sub-group of adults with type 2 diabetes and established cardiovascular disease, who also have a form of chronic kidney disease without overt proteinuria (high levels of protein in the urine), and all others in the trial.1 The results were shared as an oral presentation at the 79th American Diabetes Association (ADA) Scientific Sessions® on 10 June in San Francisco, California, US.

This"...

Continue Reading >